Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia (Q83978305)
Jump to navigation
Jump to search
scientific article published on 22 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia |
scientific article published on 22 April 2011 |
Statements
Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia (English)
Chikashi Yoshida
Takuya Komeno
Mitsuo Hori
Tomofumi Kimura
Masami Fujii
Yasushi Okoshi
Yuichi Hasegawa
Harumi Yamamoto Mukai
Takayoshi Ito
Seiichi Shimizu
Masaharu Kamoshita
Daisuke Kudo
Atsushi Shinagawa
Norio Chikatsu
Yuriko Monma
Norimichi Watanabe
Hiroshi Kojima
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference